Bronchial Asthma Clinical Trial
Official title:
Evaluation of the Delay in Asthma Diagnosis in Children From the Lodz Region After the Program for Prevention of Allergic Diseases
The aim of the research is to assess the duration of a delay in asthma diagnosis in children after the Program for Prevention of Allergic Diseases. Risk factors for delayed diagnosis of asthma in children will also be assessed. This study will answer the question of whether this ratio depends on the time, which indirectly proves that it can be changed by local intervention programs. Prove lasting effects of the Program may contribute to planning further local interventions focused on improving medical care for patients with bronchial asthma in the Lodz region, and reduce social costs associated with this disease.
The object of this study is asthma, the most common chronic childhood disease. The disease
has become epidemic in developed countries and also in Poland. The percentage of children
suffering from bronchial asthma in Lodz is one of the highest in the country (8.5%.
Bronchial asthma in children of Lodz is a real challenge not only for doctors but also for
public health professionals. This study is to assess the long-term effects of innovation on
a national scale Prevention Program of Allergic Diseases, which was carried out in 2000-2003
in the region of Lodz. This Program has given many positive effects, most of all,
improvement in the diagnosis of allergic diseases, availability of medical specialists and
reduction the number of hospitalizations because of the disease exacerbation.
The aim of the research is to assess the duration of a delay in asthma diagnosis in children
after the Program for Prevention of Allergic Diseases. Risk factors for delayed diagnosis of
asthma in children will also be assessed. This study will answer the question of whether
this ratio depends on the time, which indirectly proves that it can be changed by local
intervention programs. Prove lasting effects of the Program may contribute to planning
further local interventions focused on improving medical care for patients with bronchial
asthma in the Lodz region, and reduce social costs associated with this disease.
Subject of study are patients under 18 age, with newly diagnosed asthma, who were under care
in Allergy Clinic in Copernicus Hospital in Lodz in 2004-2009. Selected clinic is the
largest pediatric allergy center in the region and was also the largest center participating
in the Program for Prevention of Allergic Diseases and the only center, which analyzed the
delay in asthma diagnosis among patients. Children's medical documentation will be analyzed
as far as following data were concerned: demographic data, anthropometric parameters,
information about family history of atopic diseases, asthma symptoms (cough, dyspnoea,
wheezing, reducing physical activity, and recurrent respiratory infections) and symptoms of
other atopic diseases in both the current and in the past. In addition, information will be
collected on the child's family situation, housing conditions and the presence of animals in
the house. Data obtained from the children's medical documentation will be supplemented by
telephone interview conducted with parents of the child. The group of patients with
underdiagnosed asthma will be classified as children who experienced frequent wheezing (at
least 4 episodes per year) and 1 major criterium (positive family history of allergic
diseases or symptoms of atopic as infants) or two smaller criteria (symptoms of food
allergies, the increased number of eosinophilic cells in the peripheral blood or wheezing
without infection). For each child the time from appearance of asthma symptoms (according to
the API - asthma predictive index) to diagnose the disease by a specialist will be set. This
time will be defined as duration of undiagnosed asthma. Due to the fact that the delay in
asthma diagnosis is dependent on the patient's age, the analysis will be carried out in four
groups separated on the basis of the upper and lower quartiles of respondents age.
;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02934945 -
Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients
|
Phase 4 | |
Completed |
NCT02561351 -
Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation
|
N/A | |
Recruiting |
NCT01759472 -
Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Provocation Test
|
N/A | |
Completed |
NCT01918293 -
Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma): Adult
|
N/A | |
Completed |
NCT01203904 -
Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation
|
N/A | |
Completed |
NCT01762917 -
Influence of Bag Volume Variation on the Reproducibility of Inert Gas Rebreathing
|
N/A | |
Completed |
NCT00536731 -
Symbicort Rapihaler Therapeutic Equivalence Study
|
Phase 3 | |
Completed |
NCT00930826 -
Childhood Asthma and Schooling: The Truth Unveiled
|
N/A | |
Completed |
NCT00331929 -
Respiratory Health Study of Children in Kiryat Tivon
|
N/A | |
Completed |
NCT00327028 -
Study of Efficacy of Phenytoin in Therapy of Patients With Bronchial Asthma
|
Phase 4 | |
Completed |
NCT00413387 -
Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
|
Phase 3 | |
Completed |
NCT00153283 -
Study of Efficacy of Gabapentin in Therapy of Bronchial Asthma
|
Phase 4 | |
Completed |
NCT00950794 -
Study of Salmeterol (SN408D) for Adult Asthma
|
Phase 4 | |
Completed |
NCT00142025 -
Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma
|
Phase 4 | |
Completed |
NCT00153270 -
Study of Efficacy of Sodium Valproate in Therapy of Bronchial Asthma
|
Phase 4 | |
Completed |
NCT03450434 -
XC8 in the Treatment of Patients With Bronchial Asthma
|
Phase 2 | |
Recruiting |
NCT05189613 -
Mepolizumab Effectiveness in Severe Eosinophilic Asthma and Bronchiectasis
|
N/A | |
Recruiting |
NCT04128111 -
Study on the Correlation Between TCM Syndrome, Inflammatory Phenotype and Biomarker of Bronchial Asthma
|
||
Completed |
NCT06326632 -
Comparative Effectiveness Study of Constant-Load Versus Graded Aerobic Exercise in Obese Children With Bronchial Asthma
|
N/A | |
Completed |
NCT05088512 -
The Role of Genetic Factors in the Development of Bronchial Asthma in the Kazakh Population
|